Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PCVX | Vaxcyte, Inc. | CHIEF EXECUTIVE OFFICER, Director | $55.3M | -$25.9M | -31.9% | Dec 9, 2024 |
ATHA | Athira Pharma, Inc. | Director | May 24, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|